RESTEN-MP
AVI-4126-17
Phase 2 small_molecule completed
Quick answer
RESTEN-MP for Coronary Artery Disease is a Phase 2 program (small_molecule) at Sarepta Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Coronary Artery Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed